Print Page   |   Contact Us   |   Your Cart   |   Sign In
Search
Sign In
Sign In securely
Breaking News
News & Press: Daily Updates

MMWR: Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poli

Thursday, December 14, 2017   (0 Comments)
Posted by: Pat Podolak

When included in a sequential polio vaccination schedule, inactivated polio vaccine (IPV) reduces the risk for vaccine-associated paralytic poliomyelitis (VAPP), a rare adverse event associated with receipt of oral poliovirus vaccine (OPV). During January 2014, the World Health Organization (WHO) recommended introduction of at least 1 IPV dose into routine immunization schedules in OPV-using countries (1). The Polio Eradication and Endgame Strategic Plan 2013–2018 recommended completion of IPV introduction in 2015 and globally synchronized withdrawal of OPV type 2 in 2016 (2).

MORE >>


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.